Home workouts tested as therapy for rare lung disease

NCT ID NCT06804122

Recruiting now Symptom relief Sponsor: Tampere Heart Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a 12-week home exercise program can improve exercise capacity and quality of life in 20 adults with pulmonary arterial hypertension (PAH). Participants receive guidance from a physiotherapist to do endurance and strength training at home. The main goal is to see if walking distance increases by at least 33 meters.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: exercise training (endurance and strength training at home with physiotherapist guidance)
What this could lead to: If successful, this could provide a safe, home-based exercise program that improves walking ability and quality of life for people with pulmonary arterial hypertension.
What could go wrong: This is a small, early-phase study with only 20 participants, so results may not apply to all patients. Exercise may not provide significant benefits, and adherence at home could be low.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulmonary arterial hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PULMONARY ARTERIAL HYPERTENSION

Contacts and locations

Locations

Tampere Heart Hospital
RECRUITING

Tampere, Pirkanmaa, 33300, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.